LobbyingA16Z Capital Management lobbying by quarter
A16Z Capital Management's latest lobbying report covers Q2 2026, at $880K. The four quarters Q4 2025–Q3 2026 total $2.2M. Its first report covers Q1 2023; the issues it reports most are Banking and Commodities (Big Ticket).
A16Z Capital Management
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $2.3M
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q1 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2023 | $330K | 1 |
| Q2 2023 | $340K | 1 |
| Q3 2023 | $120K | 1 |
| Q4 2023 | $160K | 1 |
| Q1 2024 | $280K | 1 |
| Q2 2024 | $660K | 1 |
| Q3 2024 | $450K | 1 |
| Q4 2024 | $370K | 1 |
| Q1 2025 | $650K | 1 |
| Q2 2025 | $840K | 1 |
| Q3 2025 | $1.3M | 1 |
| Q4 2025 | $710K | 1 |
| Q1 2026 | $660K | 1 |
| Q2 2026 | $880K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Banking$1M · 14 reports
- Commodities$1M · 14 reports
- Financial institutions and securities$1M · 14 reports
- Health issues$1M · 14 reports
- Science and technology$966.3K · 13 reports
- Aerospace$898.3K · 12 reports
- Homeland security$898.3K · 12 reports
- Taxation$724K · 8 reports
- Natural resources$97.8K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES14 reports
- SENATE14 reports
- White House Office14 reports
- Commerce, Dept of (DOC)9 reports
- Natl Security Council (NSC)9 reports
- Health & Human Services, Dept of (HHS)8 reports
- Food & Drug Administration (FDA)5 reports
- Centers For Medicare and Medicaid Services (CMS)4 reports
- Office of Management & Budget (OMB)4 reports
- Office of Science & Technology Policy (OSTP)4 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseA16Z Capital Management | $7.8M | 14 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| BENJAMIN NAPIER | Clerk, House Committee on Rules (15-16); Floor Assistant, House Majority Whip (16-17); Director of Floor Operations, Rep. Whip Steven Scalise; Floor Director, Office of the House Minority Whip (19-23); Floor Director, House Majority Leader (23-25) | Q2 2026 |
| COLIN ROM | FDA Sr.Adv.(20-21); FDA Advisor (19-20); OMB Confidential Asst. (18-19); RA/LA/SA/ Sen. Burr (14-18) | Q2 2026 |
| COLLIN MCCUNE | HFSC Deputy Director/Director (19-22); HRules Policy Director (18-19);HT&I Director (14-18); LC/LA/SA Rep. Shuster (13-14) | Q2 2026 |
| JOSH ARNOLD | Exec. Assistant Rep. Jordan (15-16); Dept. Chief of Staff Sen. Lummis (20-22) | Q2 2026 |
| MICHAEL DAVID REED | Senior Advisor/ Dir. of Whip Op., House Min. Whip (23-25); Senior Advisor, Office of the House Speaker (21-23); CoS, Rep. Eric Swalwell (19-21); Leg. Director/Dep. CoS, Rep. Bonnie Watson (15-19); Leg. Correspondent, Sen. Robert Menendez (07-10) | Q2 2026 |
| SYDNEY PAUL | Leg Counsel & Snr. Leg Counsel, Senator Gary Peters (2015-2019); Leg Assistant, Senate Committee on Commerce, Science & Transportation (2013-2015); Deputy Scheduler, Senator John D. Rockefeller (2012-2013) | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | In-house | $880K |
| 04/20for Q1 | In-house | $660K |
| 01/20for Q4 2025 | In-house | $710K |
| 25/10/20for Q3 2025 | In-house | $1.3M |
| 25/08/08for Q2 2025 | In-house | $840K |
| 25/07/21for Q2 2025 | In-house | $790K |
| 25/04/21for Q1 2025 | In-house | $650K |
| 25/01/21for Q4 2024 | In-house | $370K |
| 24/10/20for Q3 2024 | In-house | $450K |
| 24/07/22for Q2 2024 | In-house | $660K |
| 24/04/22for Q1 2024 | In-house | $280K |
| 24/01/19for Q4 2023 | In-house | $160K |
| 23/10/20for Q3 2023 | In-house | $120K |
| 23/07/20for Q2 2023 | In-house | $340K |
| 23/05/11for Q1 2023 | In-house | $330K |
| 23/02/28for Q1 2023 | In-house | Under $5,000 |
| 23/01/25for Q1 2023 | In-house | Under $5,000 |